FindTrial
Sign In

Study to find an cross-reactive allergy reaction to penicillin in patients diagnosed with cefaclor allergy

Cross-reactivity of Penicillin in Patient with Cefaclor Allergy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005751
Enrollment
50
Registered
2021-01-08
Start date
2020-12-29
Completion date
Unknown
Last updated
2021-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University, Wonju Severance Christian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Those who have a history of immediate drug allergy to Cefaclor -Serum-specific IgE to Cefaclor through ImmunoCAP: =0.35 kU/L (Cefaclor drug provocation test is not a prerequisite.)

Exclusion criteria

Exclusion criteria: -Those who do not meet the criteria of drug allergy to Cefaclor when the medical history is checked -Those who have not completed the consent form -Those under the age of 19

Design outcomes

Primary

MeasureTime frame
Proportion of cross-reaction with penicillin antibiotics in patients with Cefaclor allergy—

Secondary

MeasureTime frame
The accuracy of the cross-reaction through the amoxicillin skin skin test is confirmed by conducting the drug provocation test.—

Countries

Korea, Republic of

Contacts

Public ContactJi-Ho Lee

Yonsei University, Wonju Severance Christian Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026